Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
45 Cards in this Set
- Front
- Back
Risk factors to cancer
|
-tobacco
-alcohol -drugs; immunosuppressant, chemotherapy -genetic predisposition -immune deficiency -epstein-barr lymphoma -herpes simplex, megalovirus, HPV -radiation exposure -age -occupational-asbestos -sunlight -diet-high fat and calories -urban dwellers -stress hormonal |
|
Primary prevention
|
--prevention of cancer before it occurs
-avoiding carcinogens, life-style changes, sunscreen --screening, ID at risk groups, Pap |
|
secondary prevention
|
-early detection and interventions
-removing pollups during colonoscopy |
|
Seven Warning signals
*CAUTION* |
C-change iin bowel or bladder habits
A-a sore that does not heal U-unusual bleeding or discharge T-thickening or lump in breast or elsewhere I-indigestion or difficulty swallowing O-obvious change in wart or mole N-nagging cough or hoarseness |
|
Nursing goals for cancer
|
-prevention
-rehab -management and education -detection -assist w/ treatment |
|
Onco =
Ology = |
onco=cancer
ology=study of |
|
neoplasm
|
-neoplasm is now formation, new a abnormal growth of tissue
|
|
neoplasia
|
neoplasia-uncontrolled cell growth that follows no physiologic demand
|
|
Anaplasia
|
-poor or no differentiation, >malignancy, poorer prognosis
|
|
doubling time
|
-amount of time required to deouble the cells/mass
|
|
growth fraction
|
-fraction or % of cells actively proliferating
|
|
Tumor burden
|
number of tumor cells in host
|
|
primary tumor
secondary site |
the first site of cancer
the site to where the tumor has spread |
|
Palliative treatment
|
-goal is to relieve symptoms, not cure
|
|
adjuvant therapy
|
-treatment which is supplemental to primary treatment
|
|
Two components to normal cells
|
-nucleus
-cytoplasm |
|
Cell cycle
|
cell proliferation
cell cycle controlled |
|
cell proliferation
|
-originates in stem cell and begins when it enters cell cycle
|
|
cell cycle
|
period between cell divisions plus time cell division occurs
|
|
Controlled
|
dying cells replace without surplus cells begin produced
|
|
Normal cell characteristics
|
-differientation
-contact inhibition |
|
differientation
|
-cells differ from each other, start the same but specialize
|
|
contact inhibition
|
-cells adhere to each other, like cells attract and don't crowd each other, orderly
|
|
Characteristics of cancer cells
|
-larger
-bigger nucleus -don't resemble normal cells/vary in size and shape -can't produce more than 2 daughter cells -specialized for growth and survival even under adverse conditions -no rules of growth, uncontrolled, rapid, don't recognize crowding -no purpose, no function, occupy space, acquire nutrition from host but contribute nothing -release tumor angiogenic factor (TAF) just hours after cancer site is established stimulates formation of new capillaries -center of mass-necrotic, demands of tumor for blood, oxygen, nutrients are greater that supply -cell membrane altered affecting fluid movement in and out of cell -membranes contain less fibronectin, a cellular cement -more RNA -chromosomal abnormalitites and fragility of chormosomes -DNA is substituted or permanently rearranged during mutation of stem cell |
|
Stage 1-initiation
|
-initiation-irreversible damage to DNA by carcinogen exposure (chemical, physical, biological)
-drugs, environmental, radiation, inherited chromosomal abnormalities -cells mutate -normally, these alterations are reversed by protective mechanisms and mutated cell is destroyed |
|
Stage 2-promotion
|
-promotion-repeated exposure to promoting agents cause reversible proliferation of the altered, initiated cell
-cells become progressively less differentiated -may occur after months -activity of promoters is reversible |
|
Stage 3-progression
|
progression-evolution of metastatic growth potential
-establishes blood supply -TAF produced -subpopulations (metastasis) |
|
Metastasis
|
-spread from original site to distant organs
-invasion -lymph nodes/blood -establishing of secondary site |
|
Factors influencing metastasis
|
-cells break away, they travel via
-circulatory system -lymphatic system -seeding across body cavities |
|
Abnormal but benign
|
-well differentiated
-cohesive -expansive growth -slow growth |
|
abnormal malignant
|
-poorly differentiated-cells primitive
-not cohesive-can migrate through tissues -infiltrates and expands -not encapsulated -rapid growth |
|
how does a Benign tumor effects its host
|
-plug body passages
-ulceration or infection -function as parent cell -produce enzymes that weaken or destroy adjacent cells |
|
Effects of malignant tumor on host
|
-same as benign but with added systemic effects
-compete for nutrition -necrosis -ulceration -pain -fatigue -cachexia (wasting) -toxemia -acidosis -hemorrhage -obstruction |
|
Classification of tumors
|
-staging-clinical aspects of tumor
-grading-cellular aspects of the tumor |
|
Why do we classify
|
-to determine treatment
-to determine prognosis -to evaluate results of management -statistics |
|
Grading system
|
-G1, well differentiated, low grade, closely resembles normal cells from which they arose
G2 G3 G4-poorly differentiated, high grade, retain no normal cell characteristics. |
|
Staging
|
-location and degree of metastass
-obtained by clinical, surgical, pathological means -TNM staging system T-primary tumor size/depth N-nodal involvement M-metastasis |
|
Aden
Fibro Osteo Chondro Lip |
aden-gland
fibro-fibrous tissues osteo-bone chondro-cartilage lip-adipose tissue |
|
Types of malignant tumors
|
carcinoma
sarcoma nervous tissue hematopoeitic tissue |
|
carcinoma
|
-epithelial: skin, glands, mucous membranes, linings of respiratory, GI, GU tracts
|
|
sarcoma
|
-connective tissue; muscle, fat, bibrous
|
|
Nervous tissue
|
meninges and nerve cells
|
|
hematopoeitic tissue
|
lymph and blood
|
|
Labs for cancer
|
-increased calcium
-increased acid and alk. phosphatase -increased SGPT, SGOT (liver) -total protein and albumin -increased CEA(bowel)/other tumor markers |
|
Imaging Tests
|
-radiology
-scans-CT/MRI -radioisotope scanning -endoscopy -biopsy -bronchoscopy |